Date: September 25, 2019

Time: 3:00pm EDT

Who should attend? PET Interpreters, Technologists, Referring Physicians, Marketers

In this session, Dr. Bridwell will:

• Review the potential role of FDG and NaF PET/CT in the management of breast cancer
• Detail the utilization of this imaging modality specific to the type, location and stage of the disease, as well as the clinical questions to be addressed
• Discuss where PET/CT is not recommended for imaging breast cancer, as well as the challenges this tumor type presents in diagnosis
• Utilize recent scientific literature and case studies to illustrate the proper application of this imaging test

Presenter: Robert S. Bridwell, MD, MBA SOFIE

Dr. Robert Bridwell, medical advisor to SOFIE, and co-founder of PETLinQ, is a board-certified physician in both Internal Medicine and Nuclear Medicine. He has extensive knowledge and experience in continuous quality improvement programs for PET and PET/CT imaging, utilizing physician empowerment training, protocol development assistance, and quality assurance guidelines. In the last five years, Dr. Bridwell has been invited to make numerous presentations, which have included more than 1200 hours of CME credit delivered to more than 350 institutions, 100 professional society meetings and more than 150 radiology groups throughout the United States, Canada and Europe.

Click here to register: https://register.gotowebinar.com/register/3724116651647923458

NewsSeth Werkheiser